CF-501-RBD-Fc

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCF-501-RBD-Fc
Drug Alias NameCF-501-RBD-FcCF-501/RBD-FcCF501/RBD-Fc
ClassificationVaccines
Mechanisms of ActionStimulator of interferon genes stimulantsCoronavirus spike glycoprotein inhibitors
TargetsStimulator of interferon genesCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesFudan University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A